“I Thought I Was Having a Stroke”: Erin’s Unexpected Battle with Stage 4 Melanoma

Erin is a busy mum of two, a healthcare professional, and by all accounts fit, healthy and thriving. Then, during an ordinary walk with her young children, her life changed in an instant.

After suddenly losing movement down her left side, Erin was rushed to hospital where doctors discovered a tumour in her brain. Within days, she was facing a diagnosis she never saw coming: stage 4 metastatic melanoma.

Now undergoing immunotherapy after brain surgery and radiation, Erin is sharing her story to raise awareness of melanoma’s often hidden dangers, the importance of early detection, and the life-changing impact of research.

Erin out walking.
Before your diagnosis, what was your understanding of melanoma and its potential to spread? 
Prior to being diagnosed with metastatic melanoma, I really had no idea it could spread to the brain and that it commonly does once it has grown beyond the layers of the skin.
 
Can you take us back to the day your symptoms first appeared? What happened when you suddenly became paralysed down your left side?
I was feeling well, fit and healthy when I experienced paralysis down my left side. I was out walking with my two young kids holding their hands.

“I think it would have been extremely difficult to face the diagnosis and all the emotion around it if there wasn’t such incredible treatments available. I know this is thanks to the remarkable scientists and many brave patients that have participated in clinical trials.”

 I began to squeeze my toddlers hand who was on my left side, I couldn’t control my left arm and then fell down. I first wondered if I was having a stroke. I went to the ED and had a brain CT.

Within two hours of me falling down in the street I was told I had a brain tumour which appeared to be a metastasis. Another secondary tumour was found in my left lower lung which was initially thought to be the primary. However, after undergoing surgery to remove the tumour in my brain, pathology revealed it was a melanoma.

It was a shock as I had been really sun-safe since having a melanoma in situ 10 years ago. The primary melanoma site still has not been found and it’s possible it was microscopic or was reabsorbed into my body before it could be detected and then spread.

“Knowing that healthy busy people with full lives can be silently carrying potentially lethal disease was such a huge wake-up call that melanoma does not discriminate. So, I have been incredibly open about whats happening for me as I don’t want others to put off seeing their doctor about any worrying or unusual symptoms.”

What have been some of the biggest challenges for you and your family since learning you had stage 4 melanoma?

Needing to stop work suddenly has been a big change financially and also time away from my kids while in hospital was a huge upheaval to our normal routine. It was hard to make sense of what was happening myself and then to try to support the kids with processing their experience was a lot to navigate.

Erin travelling the world.
Has this experience changed the way you view health, illness, or life more broadly? 
It has certainly been a huge wake up call to suddenly become seriously ill and need to rethink all our priorities. You get so caught up in what you think is important and then suddenly becoming unwell you realise you need to focus on your health and recovery for yourself and your family.
 
I have also been so overwhelmed by the kindness and support of everyone that has come forward to help us in many different practical ways. I feel so grateful of having such kind people around us as its made this unbearable situation feel more bearable through all the acts of kindness and support we have received.
 
You’ve undergone a craniotomy, brain radiation, and are now receiving combination immunotherapy. What has that journey been like so far? 
I’m extremely grateful at the speed with which all of the treatment has unfolded. I am just amazed at the specialist knowledge of my treating team and the availability of cutting edge healthcare. I think it would have been extremely difficult to face the diagnosis and all the emotion around it if there wasn’t such incredible treatments available.
 
The doctors have always been positive in terms of the different treatment options such as immunotherapy. Knowing there are so many success stories from these treatments builds such hope for me and I know this is thanks to the remarkable scientists and many brave patients that have participated in clinical trials. 
Erin and her son.

“I want people to know that melanoma can be deadly and affect every part of your body, but the earlier it is detected and treated, the less of an impact it is going to have on your life and the less disabling it will be. I really hope that by reading my story it might prompt others to get their skin checked”

As someone who works in healthcare and holds a Master of Public Health, has your professional background influenced the way you’ve approached your diagnosis?

I have firstly been amazed by the compassionate care that each and every one of the health care professionals I’ve met have provided. I see how busy they are and know how much of a toll it can take on you, working in a role supporting people at what is sometimes the worst time in their lives. But I have always felt listened to and genuine care from my team.

The public health lens has definitely prompted me to want to share my story with others, hoping someone might identify with my personal story and prompt a visit to the doctor rather than putting it off, which many of us do. Knowing that healthy busy people with full lives can be silently carrying potentially lethal disease was such a huge wake-up call that melanoma does not discriminate.

Whilst I cognitively understood that early detection can make such a difference, I also recognise the mechanism in all of us that leads us to delay getting medical care as it’s easy to fob it off. So I have been incredibly open about whats happening for me as I don’t want others to put off seeing their doctor about any worrying or unusual symptoms.

Why do you believe continued investment in melanoma research is so important? 
It is life changing for someone like me to be able to access treatment that is going extend my life and potentially even lead to complete remission. This was once unheard of in a case like mine to be thinking not just of management and prolonging life but potentially being disease free 5 or more years down the line.
 
Without research into melanoma people like me will die far too young and we know the prevalence of melanoma and other types of cancer is growing in Australia. I feel we may all be touched by melanoma in one way or another in the future, so its an investment in our communities and the health of future generations.

“I would like people to understand that melanoma can happen when you are young or old, no matter how fit and healthy you are, and that not all melanoma shows up as a brown spot on your skin.”

What message would you like Australians to hear about melanoma and early detection?

I want people to know that melanoma can be deadly and affect every part of your body, but the earlier it is detected and treated, the less of an impact it is going to have on your life and the less disabling it will be.

Why did you decide to share your story publicly?
I don’t want others to go through what I have so I really hope that by reading my story it might prompt others to get their skin checked by understanding the severe health impacts of melanoma if left untreated. I also want people to protect their skin from the sun knowing that sun damage can be cumulative so even short bursts of sun exposure can be harmful.
Erin with her husband and parents.
What do you wish people knew about melanoma?
I would like people to understand that melanoma can happen when you are young or old, no matter how fit and healthy you are, and that not all melanoma shows up as a brown spot on your skin. A lesser know fact that I want people to know about is the amelanotic melanomas which lack the melanin pigment, meaning it might look pinkish, flesh coloured, red or purple. These can be harder to detect.
Scroll to Top

Privacy Policy

Australian Melanoma Research Foundation (AMRF) respects and is committed to protecting the privacy of the people whose personal information it collects. We collect personal information about individuals who are employed by us, our donors, our volunteers, other supporters, allied associations, consultants and service providers.

Information we collect

Whenever we collect personal information, we will identify ourselves as AMRF and ensure people are aware of why we are collecting information and how we plan to use it.

The type of personal information AMRF usually collects and holds includes names, addresses, telephone numbers, email addresses, donation date, reason for donation, merchandise orders and other information such as health related information pertaining to AMRF research and program delivery. This information may be collected in person, via our website on the secure payment gateway, as well as other sources.

When people visit our website, or download information from it, the following information is recorded by Google Analytics:

  • Their network location and IP address
  • The date and time of their visit, pages visited, and time spent on each page
  • Referring site details (ie the site and page they came from to arrive at this site)
  • Type of web browser they used
  • Type of operating system they used
  • JavaScript support, screen resolution, and screen colour processing ability

This information is only used for statistical and website development purposes. We make limited use of cookies on our website. We use cookies to improve the functionality of our website, and to remember user preferences when people return.

In the event where an individual shares unsolicited personal information that AMRF would not have collected for the purposes outlined above that information will be destroyed or de-identified as soon as is practicable.

How we use and disclose personal information

We collect and use stakeholder’s personal information to carry out the functions and activities of AMRF and to comply with our legal obligations, to maintain and update our records and to help us manage and provide our services.

We may also use information to ask for support and to keep people informed about the ways in which our donors and supporters help us to make a difference to raise funds for research, awareness and early detection programs.  People have the right to opt out of any communications from AMRF.  This will not stop them receiving receipts and other transactional communications as required by law.

We may disclose personal information to third parties who assist us to perform functions on our behalf (such as commercial mail preparation services, this information is permanently deleted by the provider upon completion of the service and confirmed in writing of such).  These external service providers are under a duty to maintain the privacy and security of your information in line with this Privacy Policy and to use your personal information only for the purpose for which it is disclosed.

AMRF does not use any government related identifiers, such as Medicare numbers or tax file numbers, of an individual as our own identifier.

Marketing and communications

We may use people’s information within AMRF only in connection with marketing and fundraising campaigns. We may provide marketing communications to stakeholders on an ongoing basis by telephone, electronic messages (eg. email), online (including websites and mobile apps) and other means, unless they opt out or we are subject to legal restrictions. These may include communications relating to AMRF and our programs, campaign and promotional messages, event invitations, fundraising opportunities and newsletters.

AMRF also sends transactional communications which include but are not limited to: Donation & Tax Receipts, forgotten password e-mails, event sign up confirmation and confirmations from Web forms.

To opt-out of receiving AMRF marketing communications people can:

  • Select the “unsubscribe” option in one of the marketing communications that they receive from us.
  • Send an email to: admin@melanomaresearch.com.au
  • Call us on 0419 822 969
  • Send a written request to: PO Box 574, Kent Town DC SA 5071

Security of personal information

AMRF regards the security of personal information as a priority and takes a number of precautions to protect people’s personal information from loss, misuse, unauthorised access, modification or disclosure. Specific security precautions are in place for processing online payments through payment gateway providers Stripe and PayPal which include the use of encrypted links, dedicated private connections and Secure Sockets Layer (SSL) encryption. However, the Internet is not a secure environment and although all care is taken, we cannot guarantee the security of information people provide to us via electronic means such as email.

If people become aware of any inaccuracy in the personal information, we hold about themselves, they are encouraged to contact AMRF so we can update any personal information we hold.

Anonymity

Where it is lawful and practicable, we will allow individuals to deal with us on an anonymous basis. For example, if we receive a telephone enquiry, we will not require that the enquirer gives us their name, although depending on the nature of the enquiry, we may not be able to answer it unless they do.

We can also accept gifts and other forms of support anonymously. However, provisions contained in taxation legislation require AMRF to collect the name of the donor if the donor requires a tax-deductible receipt.

Image copyright

AMRF’s reputation and goodwill is extremely important. Permission to use images featured on this website has only been given to AMRF and therefore should not be downloaded or used in any way by a third party without consent.

For information on obtaining permission for an image, please email admin@melanomaresearch.com.au.

Acceptance of terms

If AMRF updates or changes this Privacy Policy, the changes will be made on this page. Your continued use of AMRF’s website following the posting of changes will mean you accept those changes.

Contact us

If you have any questions about privacy-related issues OR you wish to lodge a complaint about a breach of this policy OR other privacy matter OR you do not wish to be contacted by us to ask for your support, please contact us by email at  admin@melanomaresearch.com.au. Alternatively our postal address is below:

AMRF
PO Box 574
Kent Town DC SA 5071

We take your privacy concerns seriously. Where you express any concerns that we have interfered with your privacy, we will respond to let you know who will be handling your matter and when you can expect a further response. We may request additional details from you regarding your concerns and may need to engage or consult with other parties in order to investigate and deal with your issue. We will keep records of your request and any resolution.

For information about privacy generally, or if your concerns are not resolved to your satisfaction, you may contact the Office of the Australian Information Commissioner at www.oaic.gov.au and on 1300 363 992.